Dexcom’s “Smart Basal” has received FDA clearance for people with type 2 diabetes using long-acting insulin. The feature will ...
DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, announced today the Dexcom G7 15 Day Continuous Glucose ...
DexCom is building increasingly user-friendly devices that continuously monitor blood glucose levels, and a new collaboration between DexCom and Google could lead to the smallest such devices yet.
Dexcom G7 is the most accurate CGM system1 approved by Health Canada, building on the trusted performance of Dexcom CGM, which is clinically proven to lower A1C, reduce hypoglycemia, and improve time ...
The FDA has cleared its first over-the-counter wearable blood sugar tracker, with Dexcom’s slimmed-down Stelo continuous glucose monitor. The agency’s green light allows adults 18 years and older who ...
DexCom To Collaborate With The Life Sciences Team At Google On The Development Of Breakthrough Technologies To Change The Future Of Diabetes Management SAN DIEGO, Aug. 11, 2015 /PRNewswire/ -- DexCom, ...
Next month, Fitbit will release their new smartwatch, the Ionic. Ahead of the device’s launch, the fitness tracker specialists have announced a partnership with glucose monitor firm Dexcom that will ...
BURNABY, British Columbia--(BUSINESS WIRE)--Dexcom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, announced today that Health Canada ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback